Skip to main content

Want a detailed portfolio tracker?

Innoviva (INVA) P/E (2010 - 2026)

Innoviva (INVA) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Innoviva (INVA) P/E is 3.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Innoviva (INVA)

YearP/EChange
20263.11-42.91%
20255.45-88.35%
202446.75+143.78%
202319.18+593.79%
20222.76-22.92%
20213.59-16.11%
20204.27-82.74%
201924.77+470.91%
20184.34-74.22%
201716.82-57.79%
201639.86-387.91%
2015-13.84+99.13%
2014-6.95-68.60%
2013-22.14-92.26%
2012-286.02+1639.74%
2011-16.44-56.27%
2010-37.59N/A

Comparison Innoviva (INVA) P/E with competitors

Innoviva (INVA) P/E is 3.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.95%
NBYStablecoin Development Corp0.00-99.86%
ENLVEnlivex Ltd0.07-97.59%
FGENFibroGen Inc0.24-92.28%
CHRSCoherus Biosciences Inc0.85-72.71%
FBIOFortress Biotech Inc0.95-69.48%
ORMPOramed Pharmaceuticals Inc1.50-51.66%
AGENAgenus Inc3.01-3.21%
VXRTVaxart Inc3.55+14.17%
CRMDCorMedix Inc3.63+16.70%
CVACCureVac N.V.4.45+42.98%
GLPGGalapagos NV4.86+56.27%
SRPTSarepta Therapeutics Inc4.88+57.02%
ABEOAbeona Therapeutics Inc5.39+73.27%
ABUSArbutus Biopharma Corp5.60+79.97%
ZVRAZevra Therapeutics Inc5.89+89.34%
SPROSpero Therapeutics Inc6.23+100.32%
CGENCompugen Ltd6.31+103.07%
RIGLRigel Pharmaceuticals6.87+121.02%
SLXNSilexion Therapeutics Corp7.30+134.66%
OMEROmeros Corporation9.26+197.78%
AUPHAurinia Pharmaceuticals Inc9.58+208.27%
PLXProtalix BioTherapeutics Inc10.89+250.28%
ACADAcadia Pharmaceuticals Inc11.73+277.21%
TBPHTheravance Biopharma Inc12.26+294.37%
ADMAAdma Biologics Inc12.42+299.39%
HRMYHarmony Biosciences Holdings Inc13.82+344.48%
SABSSAB Biotherapeutics Inc14.14+354.65%
NAGENiagen Bioscience Inc14.82+376.58%
INCYIncyte Corp15.82+408.88%
REGNRegeneron Pharmaceuticals Inc15.86+409.98%
PBYIPuma Biotechnology Inc17.32+456.91%
CPRXCatalyst Pharmaceuticals Inc17.44+460.88%
EXELExelixis Inc17.54+464.06%
TGTXTG Therapeutics Inc18.97+509.99%
MDXGMimedx Group Inc20.55+561.01%
XOMAXOMA Royalty Corp22.87+635.72%
ARGXArgen X SE24.30+681.49%
CTMXCytomX Therapeutics Inc24.82+698.32%
XOMAOXOMA Royalty Corp25.34+715.16%
HALOHalozyme Therapeutics Inc25.62+724.13%
XOMAPXOMA Royalty Corp25.67+725.62%
VRTXVertex Pharmaceuticals Inc27.99+800.39%
RPRXRoyalty Pharma plc - Class A28.69+822.67%
SLNOSoleno Therapeutics Inc29.02+833.22%
ASNDAscendis Pharma A/S30.09+867.64%
LGNDLigand Pharmaceuticals Inc - Class B37.91+1119.36%
APLSApellis Pharmaceuticals Inc39.02+1155.03%
BMRNBiomarin Pharmaceutical Inc42.21+1257.65%
KRYSKrystal Biotech Inc45.34+1358.38%
ONCBeiGene Ltd69.54+2136.62%
PHARPharming Group N.V.75.03+2313.04%
TECHBio-Techne Corp101.96+3179.27%
VCELVericel Corp109.92+3435.39%
ALNYAlnylam Pharmaceuticals Inc117.96+3694.10%
GMABGenmab140.29+4412.15%
TLXTelix Pharmaceuticals Ltd162.15+5115.30%
CORTCorcept Therapeutics Inc212.86+6746.11%